Derek Brandt

livet develops rapid and reliable molecular point-of-care tests for infectious diseases in animals. Our tests allow veterinarians to take adequate measures and treat the animal based on a reliable diagnosis. This increases animal health and reduces the unspecific use of antibiotics.

Resistell proposes an alternative to culture based antibiogram, the current gold standard in antibiotic susceptibility testing. Our offering is a diagnostic device. The rapid AST method is based on the detection of movement caused by living bacterial cells. Because the test is growth independent rapid AST, we reduce the time taken to get a result from days to minutes. Resistell provides information on which antibiotic should be used to treat the patient, and the concentration at which it should be administered.

- Early Stage Investments in MedTech, Diagnostics and related Start-Ups - Active Management Support - Selective Executive Search

livet develops rapid and reliable molecular point-of-care tests for infectious diseases in animals. Our tests allow veterinarians to take adequate measures and treat the animal based on a reliable diagnosis. This increases animal health and reduces the unspecific use of antibiotics.

Resistell proposes an alternative to culture based antibiogram, the current gold standard in antibiotic susceptibility testing. Our offering is a diagnostic device. The rapid AST method is based on the detection of movement caused by living bacterial cells. Because the test is growth independent rapid AST, we reduce the time taken to get a result from days to minutes. Resistell provides information on which antibiotic should be used to treat the patient, and the concentration at which it should be administered.